Regulatory agencies require that clinical trial sponsors are able to present a summary of safety and efficacy data organized by demographic subgroups, such as age, gender and ethnicity.
In Outsourcing-Pharma’s latest webinar, which can still be accessed through the registration page, we held a discussion on the key enablers of inclusive clinical research and how there is more that still needs to be done to ensure population demographics are fairly represented in clinical trials.
The discussion featured Annemarie Forest, director of projects at the Clinical trials Transformation Initiative (CTTI), Christina Brennan, VP of clinical research at The Feinstein institutes for Medical Research, and Jasmine Benger, senior project manger of research services at the Center for information and Study of Clinical Research Participation.
During the course of the webinar, the discussion covered the following areas:
- Clinical trial participation and the factors affecting this
- How the differing ages of potential participants may impact their view of trials
- Including the patient throughout the clinical trial process
- How to improve patient diversity and what changes have occurred in recent years
- How technology and the generation of real-world data could improve participation
In addition to these talking points and others offered by our speakers, questions from our audience were also addressed. You can view the entire webinar on demand for free through this link.
The webinar was enabled through the participation of our sponsors, Capsugel by Lonza Pharma & Biotech, Marken, QPS, and Synteract.